Plasma vitamin D binding protein (DBP) may scavenge actin released during cell lysis. We examined the plasma disappearance and tissue appearance of '"I-DBP, '2I-G-actin, and the DBP-G-actin complex after their intravenous administration to rats. The plasma disappearance of DBP and DBP-actin were indistinguishable, with rapid initial (tl/2 = 2.6 h) and slower second (t/2 = 7 h) slopes. After 125I-G-actin (nanomole) injection, plasma disappearance paralleled that of DBP and DBP-actin. All injected actin was associated with DBP, without evidence of free actin, actin-gelsolin complexes or actin oligomers. Tissue appearances of 1251I-apolipoprotein (apo) or holo-DBP were similar, with highest accumulations in perfused liver, kidney, and skeletal muscle. Although more complex phenomena (plasma entry of F-actin and intracellular actin binding proteins) would occur in vivo after cell lysis, our results suggest a role for DBP in the sequestration and disposition of actin monomers in the circulation.
Introduction
The human plasma vitamin D-binding protein (DBP)' is a 58,000-D interalpha globulin possessing one sterol binding site per molecule (1) (2) (3) . 25 -hydroxycholecalciferol is bound with the highest affinity (10-8 M) , but normally occupies < 5% of available binding sites (4) . DBP is synthesized in the liver (5) and is increased during states of estrogen excess (pregnancy, oral contraceptives) and decreased in hypoproteinemic states (6) . However, changes in 25-OHD3 concentrations have no effect on the DBP concentration in serum. No human, avian, or other mammalian plasma devoid ofDBP has been found (7) .
Studies ofthe kinetic behavior ofDBP in rabbit (8) and man (9) revealed a plasma t1p that was briefcompared with 25-OHD3.
In the rabbit the half-life of 1251I-DBP was 40 h, whereas that of [3H]25-OHD was 11 d (8) . DBP normally circulates in high concentrations in the plasma of rats and man (4, 10) with concentrations of 5-8 MM (11, 12) . DBPs plasma concentration is 50-100-fold greater than its sterol ligands (8) . The calculated mean production rate of DBP in humans was -0.42 mg/kg body wt per h (9) , indicating DBP to be a high capacity system for the equimolar ratio (1 1) with high affinity (10-9 M) (13) (14) (15) . Plasma gelsolin, a 93,000-D calcium dependent actin binding protein, binds G-actin in a 1:2 M ratio (16) . Gelsolin severs F-actin filaments in the presence of calcium, whereas DBP inhibits polymerization of G-actin to F-actin (5, 16, 17) . It has been proposed that plasma gelsolin and DBP might act in concert to scavenge actin released into the circulation after tissue injury, thereby accelerating its plasma clearance, preventing polymerization to F-actin, or disassembling preformed actin filaments (14, (16) (17) (18) . Accordingly, we examined the plasma disappearance and tissue accumulation of radiolabeled DBP, DBP-actin complex, and G-actin in rats. Our experiments revealed that apolipoprotein (apo) and holo (G-actin)-DBP, and G-actin were cleared rapidly, and that their plasma clearances and tissue appearances were indistinguishable.
Methods
Materials. All chemicals used were of reagent grade or the best grade available. Bovine serum albumin (BSA), rat serum albumin (RSA), and lactoperoxidase were purchased from Sigma Chemical Co. (St. Louis, MO) . Ultra-gel AcA 44 was obtained from LKB Instruments (Gaithersberg, MD). Sodium "5I and sodium '13I were purchased from Amersham Corp. (Arlington Heights, IL). IgGsorb for immunoprecipitation was obtained from The Enzyme Center, Inc., (Malden, MA). Male SpragueDawley rats were obtained from Charles River Breeding Laboratories (Wilmington, MA).
Procedures. DBP was isolated from rat plasma as previously described (19) and yielded a single band on 7% sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis. DBP was stored at -20'C until used and its concentration determined by the method of Lowry (20) using BSA as the reference standard. G-actin was obtained from rabbit skeletal muscle acetone-dried powder, using the method of Spudich and Watt (21) . Before use, G-actin was dialyzed against buffer A (0.01 M Tris, 0.2 mM CaCI2, 0.5 mM Na-ATP, pH 8.0) for 18 to 24 h and its concentration was determined by its extinction at 290 nm. The actin was always used within 4 d of its preparation.
Radiolabeling ofpurified DBP, RSA, and G-actin. 40 fig of purified rat plasma DBP and 160 ,ug ofG-actin were radiolabeled with 1251 using the lactoperoxidase method (22) . The '25I-DBP was purified by molecular sieve chromatography on a calibrated Ultra-gel AcA 44 column (2.5 X 60 cm) under constant pump pressure at 4VC in PBS (150 mM NaCl, 10 mM Na phosphate, pH 7.4).
Monomeric, 125I-G-actin, was isolated by filtration on an AcA 44 column (1.1 X 60 cm) at 40C under constant pump pressure with buffer A. This radiolabeled G-actin was assessed for its ability to polymerize when 100 mM KCI and 2 mM MgCl2 were added to native G-actin.
Fractions of 1251I-DBP and 1251I-G-actin were collected and aliquots were counted in a gamma counter to determine the elution of DBP and G-actin. Specific activities for DBP of 0.5-4.0 MCi/Mg were achieved. The specific activity of G-actin was 0.04 MCi/Mg. 50 g ofRSA were labeled with 13'I by the lactoperoxidase technique and purified on a calibrated, 1 X 60 cm column of AcA-44 at 40C. To provide in vivo evidence ofthe purity of our DBP, 80 ,ug of DBP were radiolabeled as above with 0.6 mCi of 1251. One rat received 152 MCi ofthis '25I-DBP. After 45 min, this screening rat was bled via cardiac puncture and the plasma was separated. A second rat then received 1.5 MCi (370 ,l) of the screening rat's plasma. This rat was then studied for the disposition of the screened '251-DBP.
In separate experiments, rats were injected with 40 Mg of labeled Gactin (1.6 MCi) or with both 3'I-RSA and 1251-DBP. 10 rats each were injected with 125I-DBP or '2I-DBP-actin complex. Five rats were injected with labeled monomeric actin, and four rats received '31I-RSA and 1251. DBP simultaneously. One rat received the screening rat's 1251I-DBP plasma.
Hematocrits were determined in all animals pre-and postexperimentation.
Blood radioactivity. 2 min after injection, 200 Ml of blood were obtained by cardiac puncture using a syringe with a 27-gauge needle. Blood was transferred to 1 cm3 Eppendorf centrifuge tubes containing 10 Al Serial blood samples were obtained, and their radioactivity was expressed as the percentage of that in the 2-min sample.
Immunoprecipitation. Antiserum to rat DBP was raised in rabbits and the antibody purified on a protein A-Sepharose 4B column. The final dilution ofthe antibody after purification was 1:3, and this antibody displayed recognition ofDBP and the DBP-actin complex. The optimal amount of antibody required to precipitate all the DBP was determined by mixing serial dilutions (200 MI) with IO-Ml samples of rat plasma after the addition of25-hydroxy-[3H]vitamin D3 (10,000 dpm). After an overnight incubation at 4°C, 10 Ml of IgGsorb (IgG binding capacity, 1.18 mg IgG/ml) were added with gentle shaking for 20 min. These samples were centrifuged at 1,000 rpm for 20 min. The radioactivities in the supernatant and pellet were determined in the liquid scintillation counter (Packard Tri-Carb, Packard Instruments Co., Inc., Downers Grove, IL).
Plasma samples (10 Ml) from two rats who received '25I-G-actin were handled as above using 200 Ml of a 1:3 dilution of the antibody. Immunoprecipitable radioactivity, representing that bound to DBP, was determined by gamma spectrophotometry.
Tissue appearance of radioactivity. 2 h after the administration of 25I-DBP or 125I-DBP-actin complex, the animals were anesthetized with ether and a longitudinal middle abdominal and chest incision was made to the viscera. A heparin containing catheter was placed within the left ventricle, and the plasma was obtained and separated as previously described. The right femoral vein was then severed and the animals were perfused with ice-cold PBS via the cardiac catheter. The perfusion was continued until the organs were blanched (20-30 min) . Small organs were harvested into plastic scintillation vials and their radioactivity determined in a Packard 3001 gamma spectrophotometer. The entire liver and a portion of the liver and skeletal muscle from the anterior thigh opposite the severed femoral vein were weighed. Radioactivity was determined on the weighed portions of the liver and skeletal muscle.
Dual tracer studies. In a separate set ofexperiments, rats were injected with both '251-DBP and '31I-RSA. Without perfusion, rats were sacrificed and the organs harvested at regular intervals after injection, and plasma and tissue ratios of 1251/131I were determined by double channel gamma spectrophotometry.
For urine and stool collections, each rat was housed in a metabolic cage and all urine and stool was collected separately. The first 24-h urine was collected on ice.
Plasma samples and samples from the first 24-h urine collections were analyzed by gel electrophoresis using 10% polyacrylamide separating gel as previously described (23 In the tissue accumulation analysis, total plasma radioactivity was determined for each rat by correcting the 30-i aliquot for the total plasma volume (28) . Total skeletal muscle weight was assumed to be 45.4% of the mature rat's total body weight (29 with the more rapid plasma egress of '25I-DBP ( Fig. 1 Plasma disappearance of'25I-DBP, DBP-actin complex and '25I-G-actin. Fig. 3 A depicts the plasma disappearances ofTCAprecipitable radioactivity after the injection of '251-apo-DBP, the '25I-DBP-actin complex, or the 1251-DBP previously screened in another rat. Though not depicted in Fig. 3 , the 24-h % of dose as TCA-precipitable radioactivity was 6.2±3.4 for DBP, 4.65±3.4 for DBP-actin, and 5.0 for 125I-screened DBP. These values were clearly different from the same time points for albumin (Fig. 1) . In all instances, the TCA-precipitable radioactivity was > 85% of total radioactivity. The curves are nearly identical, with a t112 of 2.6 h. Fig. 3 B shows the plasma clearances of injected 125i- resents the rate ofdegradation, production rates were calculated based on both t/2 values. Using the faster slope with t/2 of 2.6 h, the production rate was 5.7 mg/kg per h. The rate using the second, slower half time of 7 h was 2.1 mg/kg per h.
Tissue accumulation of'25I-DBP or '25I-DBP-actin complex radioactivity in saline perfused organs. After the administration of either '23I-DBP or 123I-DBP-actin complex the organ distribution of radioactivity, after perfusion with saline, revealed the greatest accumulations in skeletal muscle, liver, and kidney (Table III). The radioactive accumulations in organs from rats receiving DBP were not statistically different from the DBP-actin organs (P = 0.4 for skeletal muscle; P = 0.3 for liver; P = 0.35 for kidney).
Properties of radiolabeled materials in plasma and urine. Electrophoresis of rat plasma obtained at 6 h after the injection of 1211-DBP by 10% PAGE revealed most ofthe radioactive material to be intact DBP (Fig. 4 A) . In contrast, urine from the first 24 hour collection revealed small-sized material with a net negative charge running at the dye front, suggesting the presence of iodine and iodopeptides (Fig. 4 B) . PAGE analysis of plasma from '31I-albumin injected rats showed the larger molecular weight material to be intact albumin (Fig. 4 C) . Urine analysis revealed small sized, negatively charged particles near the gel front, as in the case of '25I-DBP. Of the '3'I and "23I in the urine, no intact proteins were detected.
Sucrose density ultracentrifugation. The sedimentation profiles of injected materials and plasma samples are shown in Fig.  5 . The plasma samples of '23I-DBP and DBP-actin complex treated rats (Fig. 5 C) had sedimentation profiles similar to the injected materials (Fig. 5 A) with apo-DBP sedimenting more slowly than the actin-DBP complex. The monomeric actin injected (Fig. 5 B) revealed a sedimentation slower than BSA. However, representative plasma samples, (Fig. 5 D) , from rats receiving '25I-G-actin sedimented at 5-6S, as did the actin-DBP complex. No aggregation, degradation nor free monomeric actin was detected. In addition, no faster sedimenting compounds suggesting the binding of actin to gelsolin were seen when the '25I-G-actin plasma samples were run on gradients made in 1 mM CaCl2.
Discussion
The present data indicate that DBP is cleared from the rat circulation faster than rat serum albumin. In addition, the accumulation of DBP radioactivity in rat tissues was faster than albumin accumulations (Figs. 1 and 2 ). As observed in rabbits (8) observations that urine DBP radioactivity was exclusively small sized, negatively charged material (Fig. 4) .
As with all purification and protein-modification schemes, one must be concerned that the products studied behaved as would the native proteins. In addition to their identical physiochemical features to the reference proteins, functional similarities were sought. Labeled G-actin was shown to polymerize along with carrier G-actin to F-actin. '251-DBP was shown to bind mole per mole with G-actin. Finally, no differences were found in the plasma disappearance kinetics when using either '251I-DBP previously screened in one rat or '25I-DBP purified on the AcA 44 column (Fig. 3) . Unlike earlier observations (2), rat DBP exhibited no tendency to aggregate during our experimental procedures.
Since the ratio ofplasma DBP to its sterol ligands is so high, several observers have suspected functions for this protein beyond the storage, solubility and transport of vitamin D sterols (13, 14, 31) . Studies have revealed a high affinity, specific binding of DBP to G-actin (15, 23) . How might a function be carried out between an extracellular protein and a major cytoskeletal constituent? Recent studies have suggested an intimate association of DBP with the plasma membranes of immunocytes and cytotrophoblasts (32) (33) (34) (36) . These authors injected F-actin, but did not study the kinetics of G-actin directly to determine what role, if any, gelsolin played in the disposition of monomeric actin. Only TCA-precipitable radioactivity was determined in their analyses, and the integrity of the labeled proteins was not verified. It is possible, however, that there are species differences in the disposition of the DBP-actin complex.
Our results clearly show DBP to be the major plasma component in vivo for the disposition of G-actin (Figs. 3, 5 , and Table II ). Virtually all of the injected G-actin in plasma was associated with DBP as evidenced by our immunoprecipitation data with monospecific anti-rat DBP, and no aggregates or actin fragments were detected. The sucrose gradient analysis in 1 mM CaCI2, which should favor the continued binding of gelsolin to actin if it had occurred in vivo, failed to show complexes that sedimented faster than the DBP-actin complex. The clearances ofDBP, G-actin, and the DBP-actin complex from plasma were nearly identical. These findings suggest a constitutive role for DBP in the disposition and survivorship ofplasma G-actin. Our studies examined the fate of a relatively small amount of actin, since the plasma DBP capacity to bind actin (as estimated from plasma DBP concentration and binding studies) is in the order of 500-600 ,g/ml plasma.
One can presume that the introduction of critical concentrations of actin ( 15) into the isotonic milieu of plasma would result in its polymerization and disastrous hemodynamic consequences were it not for a mechanism to prevent F-actin formation. Our present results clearly indicate DBP to be a major component in the extracellular handling ofG-actin. Others have identified a possible role for gelsolin in the plasma binding and disposition of F-actin (31, 36) . Since this protein severs F-actin, its action along with the monomer sequestration provided by DBP may provide a dual mechanism to protect the organism from cell-liberated actin moieties. The precise nature of actin liberated during cytolysis is not known, however, and a plethora of intracellular actin binding proteins are likely to be released during this process (37) . Some in vivo evidence for the presence of plasma DBP-actin complexes is provided by observations in plasma from pregnant women (38) and patients with hepatic necrosis (39) .
Additional work, at various actin concentrations or conditions leading to in vivo tissue injury and cell lysis, are necessary to further characterize the in vivo mechanism for extracellular actin disposal. Our results, however, appear to indicate a major involvement of DBP in such a mechanism.
